Prostate Cancer Awareness Month Results
No One Fights AloneThank you to everyone who voted and helped us decide who came out on top in this head-to-head match
featuring four prostate cancer organizations. See below for the final results*.
Voting ended at 11:59 PM (EST) on September 30, 2022
You can still support these charities all year long even though voting has ended.

Movember’s goal is to change the face of men’s health on a global scale by funding more than 1,250 men’s health projects around the world focusing on prostate cancer, testicular cancer, and men’s mental health and suicide prevention. They are challenging the status quo, shaking up men’s health research, and transforming the way health services reach and support men.
Learn more at Movember.com.

The Prostate Cancer Foundation (PCF) funds the world’s most promising research to improve the prevention, detection, and treatment of prostate cancer and ultimately cure it for good. Their vision is to end all deaths from prostate cancer by raising awareness and funding urgent, cutting-edge, life-saving research. Learn more at PCF.org.

ZERO – The End of Prostate Cancer is a national nonprofit with the mission to end prostate cancer and help all who are impacted. ZERO advances research, provides support, and creates solutions to achieve health equity to meet the most critical needs of prostate cancer patients and their families. Learn more at Zerocancer.org.

The Prostate Cancer Research Institute’s (PCRF) mission is to improve the quality of prostate cancer patients’ and caregivers’ lives by supporting research and disseminating information that educates and empowers patients, families, and the medical community.
Learn more at PCRI.org.
Key Facts About Prostate Cancer
About 1 in 8 men will be diagnosed with prostate cancer during his lifetime
In 2022, there will be about 268,490 new cases of prostate cancer
6 cases out of 10 are diagnosed in men who are 65 or older
Data provided by: American Cancer Society https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html
CareMed is un-matched in Prostate Cancer Pharmacy Care
Innovative and personalized Prostate MTM program for eligible patients
Clinical programs developed by Board-Certified Oncology Pharmacists
Free overnight delivery to a patient’s doorstep
See how CareMed can help your urology patients
CareMed dispenses these prostate cancer and urology medications**
Erleada® (apalutamide)
Firmagon® (degarelix)
Jevtana® (cabazitaxel)
Keytruda® (pembrolizumab)
Lupron® (leuprolide)
Nubeqa® (darolutamide)
Orgovyx® (relugolix)
Taxotere® (doxetaxel)
Trelstar® (triptorelin)
Xtandi® (enzalutamide)
Yonsa® (abiraterone acetate, micronized)
Zytiga® (abiraterone acetate)
If you are a provider and would like to refer to CareMed,
click here for prescribing information.
**This list is a small portion of the comprehensive medications CareMed can provide.